MARKET

GRFS

GRFS

Grifols S A
NASDAQ
8.43
-0.03
-0.35%
After Hours: 8.43 0 0.00% 19:30 11/06 EST
OPEN
8.30
PREV CLOSE
8.46
HIGH
8.55
LOW
8.26
VOLUME
610.35K
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
6.86
MARKET CAP
5.80B
P/E (TTM)
10.46
1D
5D
1M
3M
1Y
5Y
1D
Grifols: Plasma, Profits, And Recovery Gathering Momentum
Seeking Alpha · 5d ago
Grifols Q3 Net Profit Rises, Revenue Up 8.4%; On Track To Meet 2026 Guidance
NASDAQ · 5d ago
Grifols S.A. reports Q3 results; says on track to meet its 2026 guidance
Seeking Alpha · 5d ago
Grifols (GRFS) Q3 2026 Earnings Call Transcript
The Motley Fool · 5d ago
Grifols Reports Q3 2026 Revenue and Profit Growth
TipRanks · 6d ago
Grifols Approves €0.15 Interim Dividend Per Share
TipRanks · 6d ago
Grifols Reports Q3 Revenue €2.04B, Up 8.4% YoY; Adj EBITDA €538M; Says On Track To Deliver FY26 Outlook
Benzinga · 6d ago
Weekly Report: what happened at GRFS last week (1026-1030)?
Weekly Report · 6d ago
More
About GRFS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Webull offers Grifols SA - ADR stock information, including NASDAQ: GRFS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRFS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRFS stock methods without spending real money on the virtual paper trading platform.